Latest news

Blog

Pan-Cancer Comprehensve Assay Plus - Webinar Replay 22/06
Below you can watch our Webinar Replay about the Pan-Cancer Comprehensve Assay Plus, presented by our speaker Dr. Noemí Rives, PhD.     Our Pan - Cancer Comprehensive Assay PLUS analyses over 500 genes and provides clinicall...
23/06/2021
Ver más >
MicroVE Vaginal and Endometrial Microbiota and BioER Endometrial Receptivity- Webinar Replay 17/06
Below you can watch our Webinar Replay about the MicroVE and BioER tests, presented by our speaker Dr. Luis A. Alcaraz, PhD.     Our MicroVE tests analyse the vaginal and endometrial microbiome to ensure that the female repr...
21/06/2021
Ver más >
Upcoming Free Webinars
MicroVE and BioER tests - Thursday 17th of June at 13:00 CET Our speaker Dr. Luis A. Alcaraz, PhD will tell us all about Micro VE and BioER tests: MicroVE: Analyses the vaginal and endometrial microbiome to ensure that the female reproductive ...
15/06/2021
Ver más >
Interviewing Noemí Rives - Head of R&D at Bioarray
Watch our interview with Dr. Noemí Rives, head of R&D at Bioarray! Noemí was also the speaker in our webinars about the Advances in Cancer Diagnosis using NGS on the 23rd and 24th of March 2021.
30/03/2021
Ver más >
Advances in Cancer Diagnosis using NGS - Webinar 24/03
Below you can watch the recording of our webinar about Advances in Cancer Diagnosis using NGS delivered by our specialist Dr. Noemí Rives. Get to know the latest tests using NGS as a precise diagnostic complement: - Solid Tumor (somatic ...
25/03/2021
Ver más >
Genetically abnormal human oocytes are more common than we thought
A current study published in the American Journal of Human Genetics, carried out by a team at Washington State University has shown that around 7% of the time oocytes have an unbalanced number of chromosomes. This is due to failures in recombinati...
17/12/2020
Ver más >
Test de réceptivité endométriale : tout ce que vous devez savoir
Le test de réceptivité endométriale (BioER) est un test génétique, basé sur l'analyse d'un petit échantillon de la muqueuse endométriale de la femme, pour savoir quel jour serait le meilleur pour transférer l'embryon au niveau de l’utérus, penda...
15/12/2020
Ver más >
Endometrial Receptivity test: All you need to know
The Endometrial Receptivity test (BioER) consists of the genetic analysis of an endometrial lining tissue sample in order to determine when is best for transferring an embryo into the uterus for the in vitro fertilization procedure. In this art...
24/11/2020
Ver más >
Séquençage de l'exome pour le diagnostic clinique
Le séquençage de l'exome est un test très utile en tant qu'outil de diagnostic clinique , car il permet l'identification de variations génétiques capables de provoquer différents types de maladies. Un exome est connu comme la partie du génome f...
12/11/2020
Ver más >
Exome Sequencing for Clinical Diagnosis
Exome sequencing is a key tool for clinical diagnosis, as it allows us to identify genetic variations which are capable of causing many types of inherited diseases. The exome is the part of the genome which if formed by exons. These are fractio...
12/11/2020
Ver más >
Carrier Panel (Panel des porteurs) avec NGS: Bénéfices et avantages
Par rapport aux analyses génétiques conventionnelles, qui permettent de typer un nombre limité de mutations, le Panel de Porteurs basé sur des systèmes de séquençage de masse (NGS), a augmenté les possibilités d'analyse en permettant des tests s...
30/10/2020
Ver más >
Carrier screening panel using NGS: Benefits and advantages
In comparison to conventional genetic tests, which study only a number of mutations, the Carrier Screening Panel based on Next Generation Sequencing (NGS), has increased the possibilities and efficiency of analysis, as it can simultaneously test ...
30/10/2020
Ver más >
Microarrays à l'ère NGS. Avantages dans la détection des syndromes chromosomiques.
Malgré les dernières avancées de la technologie NGS et sa puissance dans le domaine de l'analyse et de la génomique, les puces à ADN continuent d'être un outil phare dans la détection des syndromes chromosomiques grâce à leurs avantages et bénéf...
14/10/2020
Ver más >
Microarrays in the NGS Era. Advantages in chromosomal syndrome detection.
Although NGS technology has continued to develop and has great potential in the fields of analysis and genomics, Microarrays continue to be a main tool in the detection of chromosomal syndromes thanks to their significant advantages and benefits...
14/10/2020
Ver más >
The importance of gamete donor genetic screening
Two Couples Sue After Children Are Born with Genetic Abnormality Traced Back to Donors Eggs A few days ago IVF.net reported the case of two couples suing their doctor and fertility clinic in New York after giving birth to two children with a gen...
25/11/2017
Ver más >
Could PGS contribute to reducing multiple birth rates?
HFEA’s annual statistical report, released on March 2016, gathered fertility figures for cycles performed in the UK within 2014, plus live birth rates for cycles carried out in 2013. HFEA (Human Fertilisation and Embryology Authority) is the nati...
07/04/2016
Ver más >
The exome: From the study of the symptoms to mutations of genes
In this post we discuss about the wide application of exome sequencing in the clinical sector. Exome is responsible for much of the final performance of our body. The exons contain  important information which, when it is decoded, it determines ...
08/06/2015
Ver más >
New genes involved in epilepsy
Genes SIK1 and MEF2C The latest scientific research shows new genes, SIK1 and MEF2C, involved in epilepsy. Dr. Alex Paciorkowski (Assistant Professor of Neurology at the University of Rochester Medical Center) with his team, led an investigati...
03/04/2015
Ver más >
Autism and genetics: Towards a Reliable Diagnosis of Autism
The genetics of autism is a promising area of clinical study, with an important projection in the health sector. Today it is still difficult to determine the exact cause of autism. It is a disease that is more prevalent in boys than girls, incr...
08/03/2015
Ver más >
ArrayCGH: New way for detecting the root of congenital genetic cardiomyopathies
The detection of the genetic cause in patients with congenital cardiomyopathies is one of the first steps to follow in order to achieve a good clinical care on patients. For detecting in an accurate and efficient way, today we speak about arrayCG...
10/11/2013
Ver más >